03 Profile
Vital Signsby Bridgehead
Hansard to 9 November 2026 · 31,243 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Women's health & gynaecology
Regina Castaneda: no photograph is held, so the academic plate is shown instead.
Academic
Regina Castaneda
postdoctoral research fellow at Mayo Clinic and first author of the study
1
0
1
0
0
0
0
0
0
4
0
Jan 2026FebMarAprMayJuneJulyAugSeptOctNovto date
6
press citations on 1 topic since 22 Jan 2026 · last quoted 23 Oct 2026
02 Quoted on · 1 of 29 topics
Regina Castaneda: key facts
- Kind of voice
- Academic
- Role
- postdoctoral research fellow at Mayo Clinic and first author of the study
- Quoted on
- Women's health & gynaecology
- Tracked press citations
- 6
- Most recently quoted
- 23 Oct 2026
- First quoted
- 22 Jan 2026
04 The signal · where Regina Castaneda sits on women's health & gynaecology
Ranked 15= of 100 voices quoted in the press on women's health & gynaecology, level with 7 others on 6 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Dr Sue MannClinicianNational Clinical Director for Women's Health, NHS England37 - 2
Prof Ranee ThakarClinicianPresident (2022–2025), Royal College of Obstetricians and Gynaecologists; Consultant Obstetrician and Urogynaecologist, Royal College of Obstetricians and Gynaecologists (RCOG)17 - 3
Dr Alison WrightClinicianPresident, Royal College of Obstetricians and Gynaecologists (RCOG)16 - 15=
Helen HyndmanClinicianAsk Eve Lead Nurse, The Eve Appeal6 - 15=
Prof Geeta NargundClinicianFounder and Trustee, Health Equality Foundation (formerly Create Health Foundation); Life Peer (Baroness Nargund); Honorary Professor of Women's Health, City St George's, University of London6 - 15=Regina CastanedaAcademicpostdoctoral research fellow at Mayo Clinic and first author of the study6
- 15=
Hugh Taylor, MDClinicianAnita O'Keeffe Young Professor and Chair, Department of Obstetrics, Gynecology and Reproductive Sciences; Chief of Obstetrics and Gynecology, Yale New Haven Hospital, Yale School of Medicine6 - 15=Dr Paula BriggsClinicianConsultant in Sexual and Reproductive Health; Immediate Past Chair, British Menopause Society, Liverpool Women's NHS Foundation Trust6
Showing the leaders and the ranks around 15=, of 100 voices · See every voice on the topic →
05 On the record · press
What Regina Castaneda has said
By outlet · linked articles
- medicalnewstoday.com2
- everydayhealth.com1
- healio.com1
- newsnetwork.mayoclinic.org1
- tctmd.com1
Where Regina Castaneda has been quoted
- 01Hormone therapy plus GLP-1 may equal greater, sustainable weight loss for menopausal womenhealio.com · 23 Oct 2026
- 02Menopause: Hormone therapy plus Wegovy linked to more weight lossmedicalnewstoday.com · 21 Oct 2026
- 03Combining Hormone Therapy With GLP-1s May Boost Weight Loss for Menopausal Womeneverydayhealth.com · 20 Oct 2026
- 04HRT for Menopause and CV Risk: Two Observational Studies Provide Insightstctmd.com · 2 Oct 2026
- 05Menopause: HRT may boost weight loss, protect bone healthmedicalnewstoday.com · 15 Mar 2026
- 06New study links combination of hormone therapy and tirzepatide to greater weight loss after menopausenewsnetwork.mayoclinic.org · 22 Jan 2026
Verbatim
“These results are hypothesis-generating and help lay the groundwork for the rigorous clinical trials that are still needed.”
“While encouraging, these results should be viewed as hypothesis-generating. They do not mean that hormone therapy should be prescribed solely to improve weight-loss outcomes.”
“Our earlier, smaller studies showed an association between hormone therapy use and greater weight loss in postmenopausal women, and the fact that we see the same signal in a larger, independent cohort should not be overlooked”
“The study establishes a timely foundation and provides strong observational evidence that the effect on CVD risk of hormone therapy initiation among perimenopausal and recently postmenopausal women with vasomotor symptoms varies by time since menopause and race and ethnicity.”
“The study underscores the need for prospective trials to determine whether and how menopausal hormone therapy modifies response to obesity pharmacotherapy.”
“This study provides important insights for developing more effective and personalized strategies for managing cardiometabolic risk in postmenopausal women.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- AI Cytology and HPV Testing Compared in Large Cervical Screening StudyBioengineer.org
- More than 1,800 signatures back petition urging Welsh government to improve women's health careShropshire Star
- P53-assisted METTL14-mediated m⁶A modification of SLC7A11 drives ferroptosis and inflammation in polycystic ovary syndromeNature
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 10 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.